Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis - most related articles:

- Statins do not increase risk of Lou Gehrig's Disease - 10.1
- Caffeine in males with Lou Gehrig's disease - 6.8
- Low vitamin D levels seen as multiple sclerosis risk for African Americans - 5.2
- Lithium may prevent brain damage in patients with Parkinson's disease - 5.1
- CCSVI role in multiple sclerosis seems to be controversial - 4.3
- Multiple sclerosis patients should spend more time in sun - 4.1
- Pregnancy is safe for multiple sclerosis patients - 3.8
- 29 new genetic variants linked to multiple sclerosis - 3.7
- 2 new locations of genes causing multiple sclerosis - 3.5
- Cannabis is beneficial for multiple sclerosis - 3.4

Amyotrophic Lateral Sclerosis articles

Caffeine in males with Lou Gehrig's disease
Amyotrophic lateral sclerosis (ALS) is a fatal disease that damages key neurons in the brain and spinal cord. The disease causes progressive paralysis of voluntary muscles and often death within five years of symptoms.

Statins do not increase risk of Lou Gehrig's Disease
A U.S. Food and Drug Administration's analysis provides new evidence that the use of statins does not increase incidence of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease often referred to as "Lou Gehrig's Disease." The analysis was reported on Monday, Sept. 29, 2008 in Pharmacoepidemiology and Drug Safety.

2 Amyotrophic Lateral Sclerosis articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
3.28